Our data suggest that combining the LAG-3+ or LAG3+CD8+ cell proportions with the CD38+ or CD38CD68+ cell proportions is more useful in patients with viral hepatitis, whereas the LAG-3+ and CD8+ cell proportions may be more useful in patients without viral hepatitis. This evidence concerns the gene CD8A and animal viral hepatitis.